Skip to main content
    P

    PDS Biotechnology Corp (PDSB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.89
    -0.03 (-3.28%)

    Market Cap: $113.39M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    PDS Biotechnology Corp (PDSB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    PDS Biotechnology (PDSB) has a latest price of $0.89 on Nov 17, 2026, 50.1% below its 52-week high of $1.79. Its price rose 6.3% over the past 12 months. The month-end price fell 99.3% over the 10 years through Oct 2026, a compound annual decline of 39.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $301.00 in Feb 2018 and its lowest $0.21 in Aug 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PDSB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PDSB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 345.3%, and over 6 months it fell 10.6%. The month-end price fell 65.5% over the 3 years through Oct 2026, a compound annual decline of 29.8%.

    PeriodChange
    1 month-2.5%
    3 months+345.3%
    6 months-10.6%
    12 months+6.3%
    12 months, with dividends+6.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-65.5%-29.8%
    5 years-88.0%-34.6%
    10 years-99.3%-39.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 278.5%, and its weakest was 2018, when it fell 96.6%.

    YearCloseChange
    2026 through Oct 2026$1.44+87.1%
    2025$0.77-52.8%
    2024$1.63-67.2%
    2023$4.97-62.3%
    2022$13.20+63.0%
    2021$8.10+278.5%
    2020$2.14-19.2%
    2019$2.65-58.7%
    2018$6.42-96.6%
    2017$187.40-25.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 11.7% below its 50-day average of $1.01 and 6.3% above its 200-day average of $0.84.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.89
    52-week high$1.79-50.1%
    52-week low$0.20+358.4%
    50-day average$1.01-11.7%
    200-day average$0.84+6.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.0%.

    MeasureValue
    1-year beta2.44
    Largest fall, 1 year-86.0%
    Largest fall, 3 years-97.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PDSB

    What is PDSB's 1-year price change?

    PDS Biotechnology's price rose 6.3% over the past 12 months. With dividends included, the 12-month total return was 6.3%.

    What is PDSB's 5-year price change?

    PDS Biotechnology's month-end price fell 88.0% over the 5 years through Oct 2026, a compound annual decline of 34.6%. These figures leave out dividends.

    What is PDSB's 52-week high and low?

    PDS Biotechnology's 52-week high is $1.79 and its 52-week low is $0.20. Its latest price of $0.89 on Nov 17, 2026 is 50.1% below the high.

    What is PDSB's beta?

    PDS Biotechnology's 1-year beta against the S&P 500 is 2.44, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 86.0%.

    Is the PDSB chart free?

    Yes. Advanced Charting for PDSB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.